
Furthermore, Belgium could share its expertise with Board members on how it reached the 90-90-90 agenda. This agenda set as objectives that 90% of all people living with HIV will know their HIV status, that 90% of all people with a diagnosed HIV infection will receive antiretroviral therapy and that 90% of all people receiving antiretroviral therapy will have viral suppression by 2020.
The Belgian presidency comes at a time when its first National Action Plan on HIV comes to an end. Belgium can demonstrate to board members and co-sponsors how this disease-specific National Action Plan was pivotal to make progress in the AIDS response in Belgium.